Journal
POSTGRADUATE MEDICINE
Volume 134, Issue 1, Pages 11-13Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/00325481.2021.2002580
Keywords
SGLT2 inhibitors; morbidity; mortality; cardiovascular diseases; diabetes; outcomes